Skip to content
Open access

Mutant p53 gains RNA-binding activity to reprogram translation and mitochondrial function

Aug 2026 · Cell Reports · Vol 45, pp. 117856 - 117856 · 0 citations · 74 references
Medicine

TL;DR

It is shown that mut p53 alters translation and promotes changes in miRNA processing and mitochondrial function, providing a mechanistic rationale for historically reported but poorly understood phenotypes.

Abstract

SUMMARY Tumor suppressor p53 is a transcription factor mutated in ~50% of cancers. Somatic mutations in the DNA-binding domain abolish tumor suppression and thus lead to a loss-of-function activity, while a small subset of recurrent “hotspot” mutants have been shown to confer gain-of-function activities. Using an intein-based μMap photoproximity labeling approach, we map the interactomes of five hotspot mutants and find that mutant p53 (mut p53) acquires interactions with RNA-binding proteins, shifts toward the cytoplasm, and shows increased proximity to structured RNA and RNA-binding proteins. CLIP (Cross-linking and immunoprecipitation) experiments show that mut p53 possesses an RNA-binding motif and is enriched at 3′UTRs, promoting ribosomal localization and localization at the mitochondrial surface. Using ribosome profiling, we further show that mut p53 alters translation and promotes changes in miRNA processing and mitochondrial function, providing a mechanistic rationale for historically reported but poorly understood phenotypes.

Read PDF

Similar papers

Aug 2026

PTBP1 controls oncogenic transcript processing and maintenance of acute myeloid leukemia.

Findings demonstrate that PTBP1 supports AML proliferation by fine-tuning the expression and splicing of AML-essential genes, providing a workflow for systematically annotating RNA-associated protein dependencies in cancer.

Zhendong Cao, Kurtis N. McCannell, Si-Xiang Yu et al. · 0 citations
Oct 2026

tRF-3021a Promotes Apoptosis Resistance and Global Protein Synthesis in Cancer Cell Lines.

tRNA-derived fragments (tRFs) are a relatively recently discovered class of small RNAs implicated in gene-regulation, particularly behaving as microRNA to degrade target mRNAs with seed-sequence matches, but there have been very few reports of a clear phenotypic role of these small RNAs in cancer cell growth and other...

Fatemeh Esmaeili, Kumarjeet Banerjee, Ajay Chatrath et al. · 0 citations
Open access Aug 2026

Proteo-genomics-guided interpretation of somatic mutations in cancer genomes.

By integrating protein structures with mutation data from 139,818 patients, this study generates detailed, functional maps of mutations for 173 cancer genes in 18+ tumor types, providing a proteo-genomic framework to characterize the effects of mutations in tumorigenesis and integrate them into workflows for clinical i...

D. Hyeon, Yu-Xiang Zhou, Wendy K. Chung et al. · 1 citation
Review Open access Aug 2026

Alternative RNA Splicing in Cancer: Molecular Mechanisms, Functional Consequences, Biomarkers and Therapeutic Opportunities

This review integrates the molecular logic of splice-site selection with the cancer-specific mechanisms that perturb it, summarizes representative isoform switches across the hallmarks of cancer, evaluates emerging technologies and clinical biomarkers, and discusses the opportunities and constraints of translating spli...

Quan-You Wu, Kai Gui · 0 citations
Open access Aug 2026

Mutant TP53 hijacks RNA-splicing factor RBM28 to suppress double-stranded RNA triggered antitumor immunity

TP53 mutation may not only compromise its multifaceted tumor-suppressive functions but also confer oncogenic properties. Here, we demonstrate that DNA-binding domain mutations of TP53 unexpectedly confer a transcriptional regulatory function, directly driving RNA-splicing factor RBM28 overexpression. Overexpressed RBM2...

Tao Xiang, Zi-Yi He, Xiao Hu et al. · 0 citations
Review Open access Sep 2026

Cancer-associated synonymous mutations target mRNA structures and protein activity.

The role of adaptive mRNA structures in regulating gene expression in mammalian cells remains poorly understood. Synonymous mutations have been linked to a range of diseases, including cancer, yet their impact on cell biology remains largely unexplored. This opinion focuses on how cancer-associated synonymous mutations...

Robin Fåhraeus · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.